Wipro announced a strategic partnership with Japan-based Takeda Pharmaceutical Company, the largest pharmaceutical company in Japan and one of the global leaders of the industry. The strategic partnership will build advanced value in Takeda’s operations by consolidating IT platforms across the organisation. As a strategic partner, Wipro will build and maintain an ‘as-a-service’ global platform for Takeda that will drive synergies across its global entities through standardisation of IT architecture. Wipro will be primary provider of IT Infrastructure management services covering Takeda’s entities across the world, touching 30,000 users in 16 different languages, operating out of data centres in Asia, Europe and America.
Sangita Singh, Chief Executive – Healthcare and Life Science Business Unit, Wipro said, “We are thrilled to partner with Takeda in its business transformation journey. Wipro is leveraging its experience in enabling global pharma companies to achieve a leaner and standardised IT workplace and implement newer business models that put patient at the core. We look forward to collaboratively partnering with the Takeda team in enabling this unique platform across its global operations.”
“Wipro will deliver the ‘as-a-service’ on demand model, which is redefining the way organisations purchase technology. With our global delivery capabilities, Wipro will drive Takeda’s IT infrastructure, consolidating and optimising resources across the organisation,” added GK Prasanna, Chief Executive – Global Infrastructure Services and Product Engineering Services, Wipro.
EP News Bureau– Mumbai
- Advertisement -
